This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: YoungTae Lim and His Pharmaceutical Invention.
Introduction
YoungTae Lim is an inventor associated with Gyeonggi-do, South Korea. His patent work includes research into piperidine derivatives designed to activate GPR119, a target relevant to metabolic disorders.
Latest Patents
Lim is named on one patent, “Piperidine Derivatives for GPR119 Agonist.” The invention describes novel piperidine derivatives, their stereoisomers, and pharmaceutically acceptable salts, along with methods for preparing them and pharmaceutical compositions containing them. The compounds are presented as GPR119 agonists with potential use in treating metabolic disorders, including type II diabetes and related conditions. The patent record lists 1 patent for Lim.
Career Highlights
Lim’s listed company affiliations include Chong Kun Dang Pharmaceutical Corporation and LG Electronics Inc. His patent on GPR119 agonists reflects work at the intersection of medicinal chemistry and potential treatments for metabolic disease.
Collaborations
Dohoon Kim and Daekyu Choi are listed as Lim’s coworkers. Their names provide context for the professional network associated with his work.
Conclusion
YoungTae Lim’s patent on piperidine derivatives highlights an effort to develop compounds that may support future treatments for type II diabetes and related metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile